Recent

% | $
Quotes you view appear here for quick access.

Keryx Biopharmaceuticals Inc. Message Board

  • stockmasterp stockmasterp Jan 28, 2013 1:22 PM Flag

    Zerenex could become leading phosphate binding therapy in a $1.5B market.

    Zerenex could become leading phosphate binding therapy in a $1.5B market. The key take-away from this morning's results is that the market for phosphate binders is large and that the Phase III data for Zerenex is exceptional.

    Sentiment: Strong Buy

 
KERX
7.98+0.23(+2.97%)Jul 31 4:00 PMEDT